Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 5-Bromopyrimidine | HCID 78344 | — |
| Reactant | HCID 86607586 | HCID 86607586 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Product | HCID 11587901 | HCID 11587901 | — |
Reaction Steps
The title compound was prepared from 3-tert-Butoxy-carbonylamino-6-methyl-pyridine-2-carboxylic acid methyl ester in accordance with the general method of example 4; step 2 using 4-amino-2-methylthiazole (CAS: [103392-01-4], European Patent EP 321115) instead of 2-chloro-4-aminopyridine to yield [6-Methyl-2-(2-methyl-thiazol-4-ylcarbamoyl)-pyridin-3-yl]-carbamic acid tert-butyl ester as a light yellow cristalline solid, MS (ISP): m/e=349.0 (M+H+). Boc-deprotection as described in example 4 step 3 yielded 3-Amino-6-methyl-pyridine-2-carboxylic acid (2-methyl-thiazol-4-yl)-amide as a light yellow cristalline solid, MS (ISP): m/e=249.1 (M+H+). Palladium catalysed arylation with 5-bromopyrimidine as described in example 20 yielded the final compound as an off-white crystalline solid, MS (ISP): m/e=327.0 (M+H+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07414060B2 |
|---|
| Source dataset | uspto-grants-2008_08 |
|---|
| ORD ID | ord-30deb680fe664a3fac8cff57d7fcf94a |
|---|
| Source note | uspto-grants-2008_08 |
|---|